Drug Type mRNA |
Synonyms- |
Target |
Action modulators |
Mechanism IL-12 modulators(Interleukin-12 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | United States | 06 Jun 2025 | |
COVID-19 | Preclinical | Canada | 06 Jun 2025 | |
Influenza, Human | Preclinical | United States | 06 Jun 2025 | |
Influenza, Human | Preclinical | Canada | 06 Jun 2025 | |
Melanoma | Preclinical | United States | 06 Jun 2025 | |
Melanoma | Preclinical | Canada | 06 Jun 2025 |